SciFi Futures
← Capabilities
Biotech & Medicine/Foundational science

Mechanistic understanding of what sleep is for

Knowing which restorative functions sleep performs and whether they can be satisfied in less time, or by other means, without long-term harm.

State of the art

DEC2/BHLHE41 P385R (2009) and ADRB1 A187V (2019) familial natural short sleep mutations reduce sleep in carriers and in knock-in mice without obvious deficit; candidate functions (glymphatic clearance, synaptic downscaling) remain unresolved.

What’s blocking it
  • No consensus on sleep's core function, so no way to verify a shortened-sleep design is not accruing damage
  • No biomarker of sleep debt, so safety can only be assessed by lifetime outcome studies
  • Known short-sleeper families are tiny cohorts with no controlled long-term follow-up

Who’s working on it

  • Ying-Hui FuResearcher
    University of California, San Francisco

    Identified the familial natural short sleep genes, five so far, and showed short-sleep alleles reduce dementia-linked aggregates in mouse models

  • Louis PtacekResearcher
    University of California, San Francisco

    Co-leads the short-sleeper family cohort work with Fu, including the 2019 ADRB1 A187V discovery

  • Maiken NedergaardResearcher
    University of Rochester and University of Copenhagen

    Showed norepinephrine-driven slow vasomotion pumps glymphatic clearance during sleep and that zolpidem suppresses it (Cell, January 2025)

  • Giulio TononiResearcher
    University of Wisconsin-Madison

    With Chiara Cirelli, authored the synaptic homeostasis hypothesis, the main rival account of sleep's function, still being tested ultrastructurally in 2025

  • Chiara CirelliResearcher
    University of Wisconsin-Madison

    Co-principal investigator of the Wisconsin sleep and consciousness lab doing the electron-microscopy work on synapse renormalisation during sleep

What to invest in

KindInvestmentScale
researchDeep longitudinal phenotyping of familial short-sleeper cohorts and knock-in primates, with cognitive, metabolic and neurodegeneration endpoints$$ $10M – $100M
researchCandidate sleep-debt biomarker discovery (CSF clearance, synaptic turnover markers) usable in awake humans$$ $10M – $100M

Depends on

A root node: no prerequisites modeled.

Required by

No other capability builds on this directly.

Sci-fi concepts in reach

Dream recording and directed dreaminggatingdirectGermline trait enhancementgatingdirect

Sources